Paradiem, LLC Horizon Therapeutics Public LTD CO Transaction History

Paradiem, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$98.98 - $115.74 $130,653 - $152,776	1,320 Added 9.74%	14,872 $1.72 Million
Q2 2023 Jul 18, 2023	SELL	$96.34 - $112.38 $2,119 - $2,472	-22 Reduced 0.16%	13,552 $1.39 Million
Q1 2023 Apr 10, 2023	SELL	$107.32 - $113.5 $278,924 - $294,986	-2,599 Reduced 16.07%	13,574 $1.48 Million
Q4 2022 Jan 24, 2023	BUY	$62.39 - $113.8 $164,959 - $300,887	2,644 Added 19.54%	16,173 $0
Q3 2022 Oct 18, 2022	BUY	$58.92 - $84.67 $41,244 - $59,269	700 Added 5.46%	13,529 $837,000

Q2 2022 Jul 11, 2022	SELL	$79.4 - $116.36 $37,318 - $54,689	-470 Reduced 3.53%	12,829 $1.02 Million
Q1 2022 Apr 15, 2022	SELL	$86.42 - $109.81 $1,555 - $1,976	-18 Reduced 0.14%	13,299 $1.51 Million
Q4 2021 Feb 03, 2022	BUY	$98.56 - $119.91 $154,246 - $187,659	1,565 Added 13.32%	13,317 $1.44 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $57,168 - $68,650	-622 Reduced 5.03%	11,752 $1.38 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $88,827 - $98,797	1,030 Added 9.08%	12,374 $1.32 Million
Q1 2021 May 18, 2021	BUY	$71.83 - $95.48 $224,396 - $298,279	3,124 Added 38.0%	11,344 $1.03 Million
Q4 2020 Jan 29, 2021	BUY	$67.0 - $84.39 $550,740 - $693,685	8,220 New	8,220 $590,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Paradiem, LLC, based on Form 13F filings with the SEC.

Stay updated on Paradiem, LLC with notifications on news.